68 filings
8-K
BLCO
Bausch + Lomb Corp
28 Feb 24
Bausch + Lomb Announces Appointment of Karen L. Ling to Board of Directors
8:12am
10-K
2023 FY
BLCO
Bausch + Lomb Corp
Annual report
21 Feb 24
4:55pm
8-K
BLCO
Bausch + Lomb Corp
21 Feb 24
Bausch + Lomb Announces Fourth-Quarter and Full-Year 2023 Results and
7:00am
8-K/A
BLCO
Bausch + Lomb Corp
13 Nov 23
Financial Statements and Exhibits
4:47pm
8-K/A
BLCO
Bausch + Lomb Corp
7 Nov 23
Departure of Directors or Certain Officers
5:00pm
8-K
cuvh6m 8qksn
1 Nov 23
Bausch + Lomb Announces Third-Quarter 2023 Results
7:02am
8-K
txkzge bdp
29 Sep 23
Poised for Significant Growth in Prescription Dry Eye Segment
4:24pm
8-K
3dkwd 34q
14 Sep 23
Bausch + Lomb Announces Pricing of Senior Secured Notes Offering
5:26pm
8-K
kubo87 6pmgno
11 Sep 23
Other Events
7:22am
8-K
otcc56l
6 Sep 23
Independent Auditors’ Report
5:28pm
8-K/A
jl6ifyn
29 Aug 23
Departure of Directors or Certain Officers
5:05pm
S-8
l5m3wranrgzr9o
2 Aug 23
Registration of securities for employees
5:14pm
S-3ASR
gfkp ivos
2 Aug 23
Automatic shelf registration
5:09pm
8-K
tab6 zaxqt
2 Aug 23
Bausch + Lomb Announces Second-Quarter 2023 Results
7:02am
8-K
9o545
7 Jul 23
Entry into a Material Definitive Agreement
7:34am
8-K
gm4lfzz
30 Jun 23
Acquisition Represents Significant Opportunity for Growth in Prescription Dry Eye Segment
8:08am
8-K
w53u61qk4r9akb vk
1 Jun 23
Bausch + Lomb Announces Key Leadership Changes
7:21am